2023 Was a tricky year for the biopharma field, with many companies downsizing and restructuring their workforces to stay afloat. There are signs of Restoration, as mergers and acquisitions picked up across the pharmaceutical and lifestyle sciences business inside the latter Component of 2023 and possess ongoing their upswing into https://sites.google.com/view/bio-sites/blog